CellWell record HH-75026
Xenobiotic Sulforaphane in Head and Neck Cancer: Beyond the Nrf2 Pathway
Alessandro Polizzi; Rossella Rotondo; Sabrina Donati Zeppa; Monia Cecati; Magdalena Smolik; Valentina Schiavoni; Angelo Montana; Valentina Pozzi; Davide Sartini; Roberto Campagna; Gaetano Isola
2026
In plain language
Narrative review reports sulforaphane activates Nrf2 but also inhibits head and neck tumour growth through apoptosis, cell cycle arrest and epigenetic modulation, and enhanced chemotherapy and radiotherapy in preclinical studies.
- Evidence
- Emerging
Cite this record: https://thecellwell.org/studies/HH-75026
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.